(Q54456467)

30 May 2018

title

Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site. (English)

1 reference

30 May 2018

1 reference

6

Robert Huber

1 reference

30 May 2018

9

Peter Goettig

1 reference

30 May 2018

8

Wolfram Bode

1 reference

30 May 2018

Mekdes Debela

1

1 reference

30 May 2018

Viktor Magdolen

2

1 reference

30 May 2018

Valerie Grimminger

3

1 reference

30 May 2018

Christian Sommerhoff

4

1 reference

30 May 2018

Albrecht Messerschmidt

5

1 reference

30 May 2018

Rainer Friedrich

7

1 reference

30 May 2018

language of work or name

English

0 references

publication date

3 August 2006

1 reference

30 May 2018

Journal of Molecular Biology

published in

1 reference

30 May 2018

volume

362

1 reference

30 May 2018

issue

5

1 reference

30 May 2018

page(s)

1094-1107

1 reference

30 May 2018

1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Mutation in kallikrein 4 causes autosomal recessive hypomaturation amelogenesis imperfecta

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

An alternatively spliced variant of KLK4 expressed in prostatic tissue

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Accurate bond and angle parameters for X-ray protein structure refinement

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Kallikrein 4 is a secreted protein.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Molecular dissection of Na+ binding to thrombin.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Refined 2 A X-ray crystal structure of porcine pancreatic kallikrein A, a specific trypsin-like serine proteinase. Crystallization, structure determination, crystallographic refinement, structure and its comparison with bovine trypsin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. The refined crystal structures of the bovine trypsinogen-pancreatic trypsin inhibitor complex and of its ternary complex with Ile-Val at 1.9 A resolution

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR).

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Rat submaxillary gland serine protease, tonin. Structure solution and refinement at 1.8 A resolution

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Distinctly different gene structure of KLK4/KLK-L1/prostase/ARM1 compared with other members of the kallikrein family: intracellular localization, alternative cDNA forms, and Regulation by multiple hormones

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Managing peptidases in the genomic era.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Structural basis of the activation and action of trypsin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

The crystal structure of the mouse glandular kallikrein-13 (prorenin converting enzyme).

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Crystal structure of a prostate kallikrein isolated from stallion seminal plasma: a homologue of human PSA

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Refined 2.5 A X-ray crystal structure of the complex formed by porcine kallikrein A and the bovine pancreatic trypsin inhibitor. Crystallization, Patterson search, structure determination, refinement, structure and comparison with its [...]

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Molecular mechanism of tissue factor-mediated acceleration of factor VIIa activity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Crystal structure of neuropsin, a hippocampal protease involved in kindling epileptogenesis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Binding of Zn2+ to a Ca2+ loop allosterically attenuates the activity of factor VIIa and reduces its affinity for tissue factor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Comparison of the esterase activities of trypsin, plasmin, and thrombin on guanidinobenzoate esters. Titration of the enzymes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Sodium, potassium, calcium, magnesium, zinc, citrate and chloride content of human prostatic and seminal fluid.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

The single calcium‐binding site of crystalline bovine β‐trypsin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Molecular mechanisms of thrombin function

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

On the size of the active site in proteases. I. Papain

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Purification, characterization, and cloning of enamel matrix serine proteinase 1

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Molecular biology of tissue kallikrein

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2006.08.003

Identifiers

DOI

10.1016/J.JMB.2006.08.003

1 reference

30 May 2018

release_dbwstqtt5rhedgklyyrnlluobm

Fatcat ID

1 reference

https://api.fatcat.wiki/v0/release/dbwstqtt5rhedgklyyrnlluobm

Fatcat

reference URL

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed ID

16950394

1 reference

30 May 2018